The association of the combination of sumatriptan and methysergide in myocardial infarction in a premenopausal woman

Archives of Internal Medicine

Volumn 159, Issue 5, 1999, Pages 511-513

  Liston, Heidi ^a   Bennett, Lori ^b,c   Usher Jr , Bruce ^a   Nappi, Jean ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c GREENVILLE HOSPITAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DILTIAZEM; METHYSERGIDE; METHYSERGIDE MALEATE; METOPROLOL; SEROTONIN 1 RECEPTOR; SEROTONIN 2 ANTAGONIST; SUMATRIPTAN; TICLOPIDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY SPASM; DRUG POTENTIATION; DRUG SAFETY; FEMALE; HEART INFARCTION; HUMAN; MIGRAINE; ORAL DRUG ADMINISTRATION; PREMENOPAUSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; FEMALE; HUMANS; METHYSERGIDE; MYOCARDIAL INFARCTION; PREMENOPAUSE; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0033535361     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.5.511     Document Type: Article

References (13)

1. Plosker GL, McTavish D. Sumatriptan: a reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1994;47:622-651.
2. Imitrex [product information]. Research Triangle Park, NC: GlaxoWellcome Inc; 1994.
3. Willett F, Curzen N, Adams J, Armitage M. Coronary vasospasm induced by subcutaneous sumatriptan [Case Reports of Papers]. BMJ. 1992: 304:1415.
4. Mueller L, Gallagher M, Ciervo CA. Vasospasm-induced myocardial infarction with sumatriptan. Headache. 1996;36:329-331.
5. Kelly K. Cardiac arrest following use of sumatriptan. Neurology. 1995;45:1211-1213.
6. O'Connor P, Gladstone P. Oral sumatriptan-associated transmural myocardial infarction. Neurology. 1995;45:2274-2276.
7. Visser WH, Jaspers NMWH, de Vriend RHM, Ferrari MD. Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients. Cephalalgia 1996; 16:554-559.
8. Ottervanger JP, Valkenburg HA, Grobbee DE, Stricker BHC. Characteristics and determinants of sumatriptan-associated chest pain. Arch Neurol. 1997;54:1387-1392.
9. Ottervanger JP, Wilson JHP, Stricker BH. Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature. Eur J Clin Pharmacol. 1997;53:105-110.
10. Ishida T, Hirata K, Sakoda T, et al. 5-HT10β Receptor mediates the supersensitivity of isolated coronary artery to serotonin in variant angina. Chest. 1998;113:243-244.
11. Sanders-Bush, Mayer SE. 5-Hydroxytryptamine (serotonin) receptor agonists and antagonists. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. McGraw-Hill Book Co; 1996:260-261.
12. Blakeborough P, Fowler PA, Ashford EA. The use of sumatriptan in patients taking migraine prophylactic agents. In: Posters and Abstracts of the Sixth International Headache Congress; August 26-29, 1993; Paris, France.
13. Moore LL, Rumack BH, eds: Dwg-Reax (R) System. Englewood, Colo: Micromedex Inc (edition expires November 30, 1998).